A previous study, using reverse phase protein array (RPPA) of 121 selected protein targets, identified differences in the protein profile between AML-SCs and the bulk leukemia and leukemic CD34+ cells from adult AML samples [55]. The gene discussed is CD34; the disease is acute myeloid leukemia.